Enovis Corporation
Health
Performance
8.1
Risk
Sell
Buy
Curious about the Scores? Learn more.

Enovis Corporation stock rating and score history

All changes in ratings, performance and outlook tracked over time.

04.06.2026
Red alert. Risk levels out of control.
24.05.2026
Pulse detected. Still fragile, but stabilizing.
ENOV
Enovis Corporation
22.25
+3.20%
8.1
Sell
Buy
Enovis Corporation

Enovis Corporation stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Enovis Corporation do? Business model and key facts

Get the full picture of Enovis Corporation: what it builds, where it operates, and how it makes money.

Enovis Corporation Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 7367

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

shop
Company facts
Damien McDonald
CEO
7367
Employees worldwide
shop
Performance
-29.73%
Last 12 months
-72.17%
Last 5 years
shop
Growth
$2,11B
Revenue year
$-824.815.000
Net income
shop
Valuation
$1,31B
Market Cap
-2.94
Price/Earnings Ratio

Stocks related to Enovis Corporation

Selected based on industry alignment and relative market positioning.

AHCO
AdaptHealth Corp.
9.87
+1.54%
8.1
Sell
Buy
AdaptHealth Corp.
PRCT
PROCEPT BioRobotics Corporation
26.89
+2.11%
7.4
Sell
Buy
PROCEPT BioRobotics Corporation
UFPT
UFP Technologies, Inc.
216.90
-0.66%
6.5
Sell
Buy
UFP Technologies, Inc.
IART
Integra LifeSciences Holdings Corporation
16.33
+1.43%
6.1
Sell
Buy
Integra LifeSciences Holdings Corporation
ATEC
Alphatec Holdings, Inc.
7.79
+1.43%
9.0
Sell
Buy
Alphatec Holdings, Inc.

Events and news impacting Enovis Corporation stock

Earnings, coporate decisions and industry developments that can affect the share price.

Enovis Corporation fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.